O. Dassonville

Université Côte d'Azur

Papers

2

Total Citations

91

H-Index

2

About

O. Dassonville is a leading surgical oncologist whose research focuses on optimizing treatment strategies for head and neck cancers, particularly squamous cell carcinoma (HNSCC) and hypopharyngeal carcinoma. Their work critically examines the evolving role of primary surgical intervention, challenging conventional paradigms in multidisciplinary care. In their highly cited 2019 review (64 citations), Dassonville provides a comprehensive analysis of surgery’s current role in HNSCC, arguing for its continued relevance amidst advances in chemoradiation. More recently, their 2023 study (27 citations) addresses the distinct challenges of hypopharyngeal carcinoma—a disease often diagnosed at advanced stages with poor prognosis—advocating for tailored therapeutic approaches that balance oncologic control with functional outcomes. This work highlights the critical need to separate hypopharyngeal from laryngeal cancer in clinical trials, a nuance often overlooked. Dassonville’s contributions are vital for clinicians and researchers seeking evidence-based guidance on surgical decision-making, organ preservation, and quality of life in head and neck oncology. Their research continues to shape treatment protocols and inspire further investigation into personalized, function-sparing therapies.

Research Focus

Key Achievements

2
H-Index
2
Papers
91
Total Citations
46
Avg Citations/Paper
🏆 Most Cited Paper
Current role of primary surgical treatment in patients with head and neck squamous cell carcinoma
64 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Université Côte d'Azur

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago